Riskpilot← Back to searchSign inGet full accessHymyX Oy
OYDissolvedY-tunnus 2832305-5Asemakatu 20-B12Dental practice care activities · NACE 8623Est. 20171 employees
Revenue 2024
EUR 341K
+6% vs 2023
EBITDA margin
16.5%
+18% vs 2023
Equity ratio
39.1%
Financial strength
Net profit 2024
EUR 26K
+45% vs 2023
| Revenue | EUR 341K | +6% |
| EBITDA | EUR 56K | +18% |
| Net profit | EUR 26K | +45% |
| Total assets | EUR 402K | -2% |
| Equity | EUR 157K | +10% |
| Employees | 1 | — |
Legal name
HymyX Oy
Y-tunnus number
2832305-5
Legal form
Osakeyhtiö
NACE code
8623 · Dental practice care activities
Founded
5. toukokuuta 2017
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on hammaslääkäripalveluiden tuottaminen sekä kaikki muu laillinen liiketoiminta. Yhtiö voi harjoittaa sijoitustoimintaa ja arvopaperikauppaa sekä myös omistaa ja hallita kiinteistöjä, huoneistoja ja osakkeita sekä vuokrata niitä ja käydä niillä kauppaa.
Address
Asemakatu 20-B12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 298 | 270 | 261 | 321 | 341 |
| Staff expenses | −54 | −37 | −65 | −84 | −59 |
| EBITDA | 66 | 58 | 52 | 48 | 56 |
| Depreciation & amort. | −2 | −2 | −23 | −15 | −12 |
| EBIT | 63 | 55 | 29 | 32 | 45 |
| Net financials | −3 | −4 | −7 | −10 | −12 |
| Profit before tax | 60 | 51 | 22 | 23 | 33 |
| Tax | 12 | 10 | 5 | 5 | 7 |
| Net profit | 48 | 41 | 17 | 18 | 26 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 359 | 360 | 418 | 409 | 402 |
| Equity | 95 | 128 | 135 | 142 | 157 |
| Long-term debt | 220 | 197 | 250 | 228 | 200 |
| Short-term debt | 43 | 35 | 33 | 39 | 44 |
| Total debt | 264 | 232 | 283 | 266 | 245 |
EBITDA margin
16.5%
This company
15.8%
Market median
+4% vs market
20202024
Equity ratio
39.1%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
16.7%
This company
18.4%
Market median
+9% vs market
20202024
Net profit margin
7.7%
This company
8.1%
Market median
-5% vs market
20202024
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20202024
Debt / equity
1.56×
This company
0.62×
Market median
-152% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LO Chief Executive Officer | Chief Executive Officer | 2017 |
RO Deputy Member | Deputy Member | 2017 |
| Former (1) | ||
KJ | Audit | 2017 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HymyX Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kari Johannes Hyvönen | Audit | 0 companies |
| Lauri Olavi Tuuliainen | Chief Executive Officer | 0 companies |
| Raimo Olavi Tuuliainen | Deputy Member | 0 companies |
| Eveliina Maaria Tuuliainen | Chairperson | 0 companies |